微信公众号

关于我们 about us

联系我们 contact us

上海复百澳生物科技有限公司

电话:400-8792-452
邮箱:fubio@fubio.cn

http://www.fubio.cn 



您现在的位置:新闻动态

2019-2-1     同行分享|CAR-T生产工艺及临床应用指南 https://mp.weixin.qq.com/s?__biz=MzU3MTA0MzI5OA==&mid=2247484537&idx=1&sn=736c6b2635217f9bf352cf0cc4415db0&chksm=fce778f4cb90f1e22ce59c3a9be5b763cca160ac2cbd1a77164802c14a9e7e9136489272efab&token=867819423&lang=zh_CN#rd

2019-1-31    最新!JAK/STAT抑制剂助力VSV-IFNβ溶瘤病毒疗法  https://mp.weixin.qq.com/s?__biz=MzU3MTA0MzI5OA==&mid=2247484533&idx=1&sn=cc9a4d83eed7ff12ae9f66065b6dfca1&chksm=fce778f8cb90f1eec16e0d6c6d5dfb166ff026b424073eff852a04bd32a44992e866eda8dced&token=867819423&lang=zh_CN#rd

2019-1-17    最新!M1溶瘤病毒成功抵御机体抗病毒免疫! https://mp.weixin.qq.com/s?__biz=MzU3MTA0MzI5OA==&mid=2247484508&idx=1&sn=bbc44d19a3e0dcd345d520cb9d6ad593&chksm=fce778d1cb90f1c732a81e5114ba252479d7053f86e5c7e2e977beba2bb29259602ad57cfd74&token=867819423&lang=zh_CN#rd

2018-12-31  重磅!溶瘤病毒疗法新突破!https://mp.weixin.qq.com/s?__biz=MzU3MTA0MzI5OA==&mid=2247484480&idx=1&sn=c43dc7c33c4312f4055987b1fdb13315&chksm=fce778cdcb90f1dbb9a16ca6a77fee799e02852ed7ce1ab398c43ea8417043797c3068c4f21e&token=867819423&lang=zh_CN#rd

2018-9-20  “补给”型溶瘤腺病毒助力T细胞治疗  https://mp.weixin.qq.com/s?__biz=MzU3MTA0MzI5OA==&mid=2247484406&idx=1&sn=385c3b0e888f7d97d402ef6cb0d6dae5&chksm=fce77f7bcb90f66d653ad01aeec48d6afd41d9cd916a798877ee3b00eee024181fc68d2e0c62&token=867819423&lang=zh_CN#rd

2018-6-14    联合用药谁更强?溶瘤病毒+PD1 VS 溶瘤病毒+CTLA-4  https://mp.weixin.qq.com/s?__biz=MzU3MTA0MzI5OA==&mid=2247484325&idx=1&sn=6e1fc54847e155b7511b1bb9774e8a20&chksm=fce77f28cb90f63ed729a0bb45ba67c66b8fb2902c8ee2837d3f03fd395736e873ab0b401845&token=867819423&lang=zh_CN#rd

2017-7-21   CAR-T疗法治疗胶质母细胞瘤首次成功穿越血脑屏障  http://news.bioon.com/article/6707071.html

2017-7-13    FDA 小组全票推荐批准诺华 CAR-T 疗法用于治疗特定类型白血病 http://yao.dxy.cn/article/523822 

2017-8-23   颜广美教授发表论文讲述了M1溶瘤病毒在VCP高表达的肿瘤中抗肿瘤效果显著

 https://mp.weixin.qq.com/s?__biz=MzU3MTA0MzI5OA==&mid=2247483854&idx=1&sn=8f8f3eea03daa7c2ac0c9241c786ef32&chksm=fce77d43cb90f455d4229e101f1ccb786d6d43b475655a6a700b362f4d8617be772b620c3a53#rd

2017-9-7   溶瘤病毒药物T-VEC(talimogene laherparepvec )和PD-1抗体药物( pem-brolizumab)对黑色素瘤进行治疗,肿瘤缓解率高达62%,其中33%为完全缓解。

https://mp.weixin.qq.com/s?__biz=MzU3MTA0MzI5OA==&mid=2247483879&idx=1&sn=1ecd0b9b92fbb8a304731447151197af&chksm=fce77d6acb90f47c8e8285ba1164518bb055acd5fd1fafbaace9f163935e6733107cf4c0abfe#rd